Spots Global Cancer Trial Database for imgn901
Every month we try and update this database with for imgn901 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
An Open-label Phase II Study of Lorvotuzumab Mertansine | NCT02420873 | Leukemia | Lorvotuzumab Me... | 18 Years - | M.D. Anderson Cancer Center | |
A Study of IMGN901 for Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer | NCT01237678 | Small Cell Lung... | IMGN901 Carboplatin and... | 18 Years - | ImmunoGen, Inc. |